Definitive Healthcare Corp. Upgrade: Validea's Price/Sales Investor Model Rewards Low P/S Ratio, Strong Free Cash Flow, and Consistent Profit Margins

Definitive Healthcare Corp (DH) has been upgraded to 70% by Validea's Price/Sales Investor model based on Kenneth Fisher's strategy. The model rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow, and consistent profit margins. DH meets criteria for total debt/equity ratio, free cash per share, and price/research ratio, but fails in long-term EPS growth rate and three-year average net profit margin.